
Midjourney expands from AI image generation into medical devices with underwater full-body scanner
The AMW Read
Midjourney's pivot into medical hardware is a radical novelty that overturns the segment's assumption that it remains a pure image-generation company; significance is segment-level (multimodal/generative media) and may cross into healthcare, but regulatory and execution risks limit immediate structu
Midjourney expands from AI image generation into medical devices with underwater full-body scanner
Midjourney has announced a new division, Midjourney Medical, and unveiled a prototype underwater full-body scanner that uses ultrasound sensors arranged in a circular water tank to create a 3D map of the human body in 60 seconds. CEO David Holz debuted the device at a members-only club in San Francisco, positioning it as a wellness tool that offers more detailed imaging than MRI in a spa-like experience. The company plans to open a 24,000-square-foot medical spa near Union Square in 2027 and aims to deploy 50,000 scanners globally by 2031. This is the first of four hardware products Midjourney is developing.
Why it matters: Midjourney's move into hardware and medical diagnostics is a striking example of a generative AI company diversifying under competitive pressure. The company rose to prominence in 2022 on the strength of its artistic image-generation model, but has since faced intense competition from platform giants like OpenAI and Google, as well as emerging rivals such as Black Forest Labs. This pivot echoes a recurring pattern among AI-native companies: when the hyperscaler-distribution moat squeezes the standalone consumer AI product, founders look for adjacencies where their brand and AI expertise can unlock new value. For Midjourney, that adjacency is wellness and diagnostic imaging — a capital-intensive, regulation-heavy bet that marks a radical departure from its software roots.
Grounded expert take: Medical professionals quoted in the article caution that the device is still at the wellness stage and warn that whole-body scans without clinical context can lead to incidental findings, unnecessary follow-ups, and patient anxiety. The U.S. Preventive Services Task Force only recommends preventive screening when clear health benefits are proven. Science communicator Hank Green noted that ultrasound technology is promising but cannot replace MRI, CT, or colonoscopy — each modality serves a different purpose. Midjourney plans to pursue FDA approval for diagnostic functions over time, but has not disclosed how health data will be stored, how billing will work, or what AI techniques will be applied. The hardware-first strategy also carries execution risk: CEO Holz previously founded Leap Motion, a hand-tracking startup that generated early hype but failed to achieve mass adoption. The skepticism from medical experts and the company's lack of regulatory clarity suggest this is a high-risk, high-reward experiment that will be defined by regulatory outcomes and clinical validity — not AI model quality.
#Midjourney #MedicalDevices #AIHardware #WellnessTech #DiagnosticImaging #CorporatePivot


